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Mesangial cell proliferation mediated by PDGF and bFGF is deter-
mined by levels of the cyclin kinase inhibitor p27'1. Mesangial cell
proliferation in vitro is regulated by many cytokines. Platelet-derived
growth factor (PDGF) and basic fibroblast growth factor (bFGF) are
potent mesangial cell mitogens, whereas transforming growth factor-/31(TGF-pI) reduces their effects. We examined how these cytokines regu-
late rat mesangial cell proliferation at the level of the cell-cycle. Quiescent
mesangial cells in vitro express the cyclin kinase inhibitor, p27'" (p27)
and PDGF- and bFGF-induced mesangial cell proliferation is associated
with a substantial decrease in p27 levels. Consequently there is a marked
increase in expression (Western blot analysis, immunostaining) of cyclin A
and CDK2. The decline in p27 levels was prevented by TGF-131 during
inhibition of PDGF- and bFGF-induced mesangial cell proliferation. To
determine the functional role of p27 during cytokine-mediated mesangial
cell proliferation, the expression of p27 was reduced with specific p27KPl
antisense oligodeoxynucleotides. Reducing the levels of p27 resulted in an
increased magnitude of mesangial cell proliferation (BrdU and 3H-
thymidine incorporation) induced by PDGF and bFGF compared to
non-transfected mesangial cells and mesangial cells transfected with
control mismatch oligodeoxynucleotides. Furthermore, the onset of max-
imal proliferation occurred earlier in mesangial cells transfected with
antisense compared to control. The reduction in proliferation by TGF-31
were not altered by decreased p27 expression. Reducing p27 expression in
the absence of mitogens was not associated with entry into the cell-cycle.
These results suggest cytokine mediated mesangial cell proliferation is
associated with specific cell-cycle proteins, and that the levels of p27 may
he important in determining the mesangial cell's proliferative response to
PDGF and bFGF in vitro.
Mesangial cell (MC) proliferation characterizes many forms of
glomerulonephritis [11. MC proliferation can be induced by many
mitogenic cytokines, including platelet-derived growth factor
(PDGF) and basic fibroblast growth factor (bFGF) [2, 3]. Abboud
and colleagues were the first to show that MC in vitro express
PDGF, and that PDGF AB and BB dimers induce MC prolifer-
ation in vitro [4]. Silver reported that growth factors such as EGF,
TGF-a, bFGF and PDGF itself induce the expression of PDGF A
and B chain [5]. Furthermore, blocking PDGF with anti-PDGF
antibody abrogated the mitogenic effect of EGF-induced MC
proliferation, suggesting that PDGF is a critical autocrine regu-
Received for publication October 8, 1996
and in revised form November 22, 1996
Accepted for publication November 25, 1996
© 1997 by the International Society of Nephrology
lator of MC proliferation in vitro. bFGF is also produced by MC,
and is a potent MC mitogen in vitro [6] and in vivo [7]. Moreover,
PDGF and bFGF increase MC proliferation in vivo in experimen-
tal mesangial proliferative glomerulonephritis [7]. PDGF and
bFGF both signal through a tyrosine kinase receptor [8], while
some of the known nuclear events include activation of the
transcription factors c-myc and c-fos [9].
Transforming growth factor-131 (TGF-/31) is a potent inhibitor
of proliferation in a variety of cell types, including MC [10, 11].
Furthermore, TGF-/31 reduces MC proliferation induced by
PDGF and bFGF [12]. Although recent studies have delineated
the binding of TGF-f31 to different serine-threonine receptor
subtypes [reviewed in 13], little is known about the signaling
pathways mediating TGF-131 [14].
Cell proliferation is ultimately governed at the level of the
cell-cycle. Under appropriate stimuli, cells exit quiescence (GO
phase) and enter the cell-cycle at Gi [15]. Progression through the
cell-cycle is dependent on the balance of positive and negative
regulatory cell-cycle proteins [16, 17]. During each phase of the
cell-cycle there is an increase in expression for specific cyclins,
which bind to their catalytic partners, the cyclin-dependent ki-
nases (CDK) [reviewed 18]. This results in the formation of active
cyclin-CDK complexes, which are responsible for the phosphory-
lation of the retinoblastoma protein as well as other substrates, an
event required for GuS transition and DNA synthesis [19]. The
D-cyclins bind CDK4 in Gi, whereas cyclin E and CDK2 complex
at GuS transition [20]. Cyclin A is complexed with CDK2 during
the S phase [21].
Cyclin-kinase inhibitors (CKI) negatively regulate the cell-cycle
by inhibiting cyclin-CDK complexes [reviewed in 221. One family
of CM include p21 Cp1 and p27 (abbreviated as p27 in this
manuscript), and the N-termini of these CKI share homology, and
can bind to and inhibit CDK. Overexpression of these CM causes
cell-cycle arrest in some non-renal cells [23]. In certain cell types,
p27 levels oscillate throughout the cell cycle, while in others there
is no change during proliferation [24].
Although the expression of cell-cycle proteins has been studied
in some non-renal cells, the expression of cell cycle regulatory
proteins in glomerular cells is poorly understood, and it is unclear
if all mitogens are associated with the same cell cycle events.
Accordingly, the first aim of the current study was to determine
the expression of cell cycle regulatory proteins in the glomerular
MC in vitro, while a second aim was to determine the expression
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of specific cell-cycle proteins following stimulation by the mito-
genie cytokines, PDGF and bFGF. Our results show that PDGF
and bFGF induced MC proliferation is associated with increased
CDK2 expression, which is not typical of non-renal cells. We show
that MC proliferation is associated with a decrease in p27 protein
levels, but unlike other cell types, the levels were always detect-
able. This result formed the basis for the third aim of the current
study, in which we determined whether the levels of p27 deter-
mine the MC proliferative response to mitogenic and anti-
proliferative cytokines. Reducing the expression of p27 in MC
with specific oligodeoxynucleotides (ODN) to p27 enhanced the
magnitude of PDGF and bFGF induced MC proliferation. Fi-
nally, we sought to determine which cell-cycle proteins are altered
during TGF-/31 inhibition of MC proliferation. Although TGF-/31
prevents the decrease in p27 levels induced by PDGF and bFGF
in MC, reducing p27 with antisense ODN did not alter the
anti-proliferative action of TGF-pl. These results suggest that
MC proliferation is controlled by a complex interplay of positive
and negative cell-cycle regulatory proteins. p27 is a critical
determinant in the MC response to mitogens, but by itself is not
responsible for the anti-proliferative effects of TGF-131.
Methods
Establishment of rat mesangial cells
Rat mesangial cells (MC) were grown in culture as previously
described [251. In brief, glomeruli were isolated by differential
sieving from kidneys of six male Sprague-Dawley rats (50 to 100
grams), and grown in RPMI media (Irvine Scientific, Santa Ana,
CA, USA) that contained 15% fetal calf serum (Summit Biotech-
nology, Ft. Collins, CO, USA), 15 mi HEPES (Sigma Chemical
Co., St. Louis, MO, USA), 89 g/ml sodium-pyruvate (Irvine
Scientific), 200 M L-glutamine (Irvine Scientific), 81 ig/ml
penicillin G, 81 j.g/ml streptomycin sulphate (Irvine Scientific)
and 0.66 U/mI insulin (Gibco BRL, Grand Island, NY, USA). MC
were passaged every 72 to 96 hours by trypsinization. MC were
identified by their typical stelate morphology, and by immuno-
staining for characteristic cytoskeletal filament proteins (desmin
and a-actin), cell-surface antigens (Thyl, thrombospondin) and
negative staining with antibodies to the leukocyte common anti-
gen OX-i or factor VIII [26]. We used passages 10 to 20 MC, and
each experiment was performed a minimum of six times.
Experimental design
Inducing mesangial cell proliferation. To synchronize MC in a
quiescent state, MC were plated at a density of 3 X j5 MC/cm2
in serum free media for 48 hours. To study protein expression,
MC were grown in 10 cm2 plates, while 24-well plates were used
for the proliferation assay using 3H-thymidine or 5-bromo-2'-
deoxyuridine incorporation into DNA. Pilot studies using flow
cytometry determined that these conditions resulted in  90% of
MC being in the GO/Gi phase. To study the temporal expression
of cell cycle regulatory proteins following mitogen stimulation of
quiescent MC, the media was replaced at 48 hours with serum free
media containing PDGF BB (PDGF) (concentration of 10 ng/ml;
Becton Dickinson Labware, Bedford, MA, USA), or bFGF (con-
centration of 10 ng/ml; Becton Dickinson Labware), and studies
were performed at 0, 6, 12, 18 and 24 hours following stimulation.
To determine the expression of cell-cycle proteins following
growth inhibition by TGF-1, separate experiments were per-
formed in which TGF-/31 (concentration 1 ng/ml; R&D Systems,
Minneapolis, MN, USA) was added to the media containing
PDGF (10 ng/ml) or bFGF (10 ng/ml), and studies were per-
formed at 0, 12, 18 and 24 hours following stimulation.
Assessment of MC proliferation
The incorporation of 3H-thymidine and 5-bromo-2'-deoxyuri-
dine (BrdU) into DNA was used as a measure of MC prolifera-
tion. A pulse of 2 Ci of 3H-thymidine (Dupont NEN Research
Products, Boston, MA, USA) was added to each well for the final
four hours of cytokine stimulation at each time point. MC were
washed three times with cold PBS then incubated in ice-cold 10%
trichloroacetic acid for 25 minutes, followed by ether-alcohol for
five minutes. The cells were solubilized with 0.2 M NaOH,
neutralized with 0.4 M glacial acetic acid and 3H-thymidine was
counted on a Beckman LS 7500 scintillation counter. To ensure
that the 3H-thymidine incorporation was standardized for cell
number, cell protein concentrations were determined in each well
using the DC protein assay (Bio-Rad Laboratories, Hercules, CA,
USA) according to the manufacturer's instructions. 3H-thymidine
incorporation is reported as counts per minute/pg protein.
To determine the number of MC undergoing entry into S phase
at 24 hours, we labeled MC with BrdU (Cell proliferation kit;
Amersham Life Science, Arlington, IL, USA) for three hours
(1:500 dilution), and performed immunostaining according to the
manufacturer's directions. Detection of bound antibody was
achieved using a peroxidase-conjugated monoclonal antibody,
followed by Diaminobenzidine with cobalt and nickel. Cameo
quick stain II (Baxter Scientific Products, McGaw Park, IL, USA)
was used as a counterstain. To determine the percentage of cells
staining positive for BrdU, 200 MC were counted in a blinded
fashion at each time point, and the percentage of MC staining
positive for BrdU was determined.
Determining the expression of cell-cycle regulatory proteins in
mesangial cells
The levels of cell-cycle regulatory proteins were determined by
immunostaining and Western blot analysis.
Immunostaining. MC were grown on four-well chamber slides,
and fixed in 3.7% paraformaldehyde for 10 minutes at room
temperature, then washed three times in cold PBS. The cells were
permeablized with 0.5% NP-40 buffer for 10 minutes at room
temperature. Following a wash in PBS, the following primary
rabbit polyclonal antibodies were incubated overnight at 4°C:
cyclin A (dilution 1:1000; provided by J.M.R.), CDK2 (dilution
1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
p27 (dilution 1:1000; provided by J.M.R.). Controls included
omitting the primary antibody, replacing the primary antibody
with an irrelevant antibody of the same species and peptide
absorption (the source for the peptides was the same as the
primary antibody). A secondary biotinylated goat anti-rabbit
antibody was added (1:400 dilution, Vector Laboratories, Burlin-
game, CA, USA) for 60 minutes at room temperature, followed by
a FITC-conjugated streptavidin (1:32 dilution; Cappel Research
Products, Durham, NC, USA) for 60 minutes at room tempera-
ture. Nuclei were counterstained with 4', 6-diamidino-2-phenylin-
dole (Boehringer Mannheim, Indianapolis, IN, USA). The num-
ber of FITC-positive cells were expressed as a percentage of the
total number of cells.
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Fig. I. Effect of PDGF on rat mesangial cell (MC) proliferation using
3H-thymidine proliferation assay. MC proliferation was determined by
3H-thymidine incorporation into DNA corrected for protein concentra-
tion in untransfected MC (LI), MC transfected with antisense oligode-
oxynucleotide (ODN) to p27'°"1 (p27) which lowered p27 levels (), and
in MC transfected with mismatch ODN to p27, used as a control for the
antisense ODN (). Serum-starved or quiescent MC were stimulated with
PDGF alone (10 ng/ml), or with PDGF (10 nglml) plus TGF-f31 (1 nglml).
In non-transfected MC, PDGF increased MC proliferation at 20 hours (20
hr), and proliferation was maximal at 24 hours (24 hr), whereas TGF-fll
reduced PDGF induced MC proliferation at 20 hours and 24 hours. There
was no significant difference (NS) in 3H-thymidine incorporation among
the three groups when serum-starved. Antisense to p27 was associated
with a significantly increased MC proliferation at 20 hours and 24 hours
following PDGF stimulation compared to untransfected MC, and MC
transfected with mismatch ODN. The onset of maximal MC proliferation
was also earlier (20 hr) following antisense transfection. TGF-1 reduced
proliferation in transfected and non-transfected MC. p < 0.05.
Western blot analysis. MC were washed three times with cold
PBS, trypsinized and following centrifugation, the pellet was
resuspended in a buffer containing 1% triton, 10% Glycerol, 20
mM HEPES, 100 mivi NaCI with 10 sg/ml leupeptin, 10 jig/mI
antipain, 10 jig/ml pepstatin, 0.1 m sodium orthovanadate and
50 mM sodium fluoride (reagents purchased from Sigma Bio-
sciences, St. Louis, MO, USA). Following a vortex, the MC were
placed on ice for 15 minutes. The cells were centrifugated at
14,000 rpm for five minutes, and the protein concentration of the
supernatant was measured by BCA protein assay (Pierce, Rock-
ford, IL, USA). For Western blot analysis, 20 jig of MC protein
extract was loaded in each lane, separated under reducing condi-
tions on a 15% SDS-PAGE gel, and transferred to PVDF
membranes (Millipore, Bedford, MA, USA) by electroblotting
[61. To reduce nonspecific antibody binding, the membranes were
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Fig. 2. Effect of bFGF on rat mesangial cell (MC) proliferation using
3H-thymidine proliferation assay. MC proliferation was determined by
3H-thymidine incorporation into DNA corrected for protein concentra-
tion, in untransfected MC (1:1), MC transfected with antisense oligode-
oxynucleotide (ODN) to p27'' (p27) that lowered p27 levels (), and in
MC transfected with mismatch ODN to p27, used as a control for the
antisense ODN (). Serum-starved or quiescent MC were stimulated with
bFGF alone (10 ng/ml), or with bFGF (10 ng/ml) plus TGF-J31 (1 ng/ml).
In non-transfected MC, bFGF increased MC proliferation at 20 hours (20
hr), and proliferation was maximal at 24 hours (24 hr), whereas TGF-/31
reduced, but did not prevent bFGF induced MC proliferation at 20 hours
and 24 hours. There was no significant difference (NS) in 3H-Thymidine
incorporation among the three groups when serum-starved. Antisense to
p27 was associated with a significantly increased MC proliferation at 20
hours following bFGF stimulation compared to untransfected MC, and
MC transfected with mismatch ODN. At 24 hours there was no difference
in MC proliferation in MC transfected with antisene or mismatch.
TGF-pl reduced proliferation in transfected and non-transfected MC.P < 0.001.
first blocked with 5% non-fat dried milk for 30 minutes at room
temperature. This was followed by a one hour incubation at room
temperature with antibodies to either cyclin A, CDK2 or p27.
Controls included omitting the primary antibody, replacing the
primary antibody with rabbit serum and peptide absorption. An
alkaline phosphatase-conjugated secondary antibody (Promega,
Madison, WI, USA) was used for detection with the chromagen,
5-Bromo-4-Chloro-3-Indolyl phosphate/nitro blue tetrazolium
(Sigma Biosciences). The gels were stained with Coomassie blue
to check for complete protein transfer, and following Western blot
analysis, filters were also stained with Coomassie blue to ensure
that protein loading was equal.
Immunoprecipitation studies. To determine if p27 associated
with cyclin A-CDK2 complexes during PDGF induced MC pro-
liferation, we performed immunoprecipitation [29]. MC protein
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Fig. 3. Mesangial cell (MC) ently into S phase following stimulation by
PDGF. In MC transfected with p27 antisense oligodeoxynucleotides or
with control mismatch oligodeoxynucleotides, and in non-transfected MC,
entry into the S phase of the cell-cycle was determined by measuring
5-bromo-2' -deoxyuridine (BrdU) incorporation into DNA. There was no
difference (NS) in BrdU staining in non-transfected MC and transfected
MC under serum-starved conditions, where less than 10% of cells stained
positive for BrdU. At 24 hours of PDGF (10 ng/ml) stimulation, there was
increased BrdU staining in non-transfected and transfected MC compared
to serum-starved conditions (*P < 0.05). In MC transfected with antisense
the magnitude of proliferation was increased compared to MC transfected
with mismatch or non-transfected MC (°°P < 0.05). TGF-/31 (1 nglml)
reduced but did not prevent PDGF induced MC proliferation in all three
groups. Symbols are: (Ii) non-transfected; () oligodeoxynucleotide; ()
mismatch.
Fig. 4. Mesangial cell (MC) entry into S phase following stimulation by
bFGF. In MC transfected with p27 antisense oligodeoxynucleotides or
with control mismatch oligodeoxynucleotides, and in non-transfected MC,
entry into the S phase of the cell-cycle was determined by measuring
5-bromo-2'-deoxyuridine (BrdU) incorporation into DNA. At 24 hours of
bFGF (10 ng/ml) stimulation, there was increased BrdU staining in
non-transfected and transfected MC compared to serum-starved condi-
tions (*P < 0.05). In MC transfected with antisense, the magnitude of
proliferation was increased compared to MC transfected with mismatch or
non-transfected MC (**P < 0.05). TGF-131 (1 nglml) reduced but did not
prevent PDGF induced MC proliferation in all three groups. Abbreviation
NS is not significant. Symbols are: (El) non-transfected; () oligode-
oxynucleotide; () mismatch.
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(200 g) from each time point was incubated with the antibody to
cyclin A (1:200 dilution) for 30 minutes at 4°C. Protein A
sepharose beads (50 1il; Repligen, Cambridge, MA, USA) were
added to each immunoprecipitation and incubated for 30 minutes
at 4°C. Negative controls included substituting for the primary
antibody with pre-immune rabbit serum. Reducing sample buffer
was added to each tube, the samples were boiled for five minutes
and the supernatant was then separated on a 15% SDS-PAGE
and transferred to a PVDF membrane (Millipore), where it was
incubated with an antibody to p27.
Reducing the levels of p27 with anti -sense
To determine the functional role of p27 in MC in Vitro fl
response to proliferative and anti-proliferative cytokines, we
undertook studies to reduce the expression of p27 in MC using
antisense oligodeoxynucleotide transfection as recently described
[271. The oligodeoxynucleotides were synthesized on an auto-
mated synthesizer (model 8750; Milligen Bioresearch, Bedford,
MA, USA), and the antisense sequence used was 5'-UGG CU-
CUCC UGC GCC-3', and the mismatch sequence was 5 '-UCC
CUU UGG CGC GCC-3'. We have shown that the mismatch
oligodeoxynucleotides used in the current study are specific for
p27, and do not effect the expression of other cell-cycle proteins
[27]. The oligodeoxynucleotides were mixed with the liposome
GS2888 cytofectin (Gilead Scientific, Foster City, CA, USA) as
previously described [27].
Pilot studies were performed to optimize the conditions for the
current study. To determine the concentration of ODN required
to reduce the expression of p27, studies were undertaken with
ODN at concentrations of 100, 50, 25, 10 and 1 nmol, each with a
different concentration of liposome ranging from 1 to 5 jig/ml.
Levels of p27 were measured by Western blot analysis. To assess
the cytotoxicity of each concentration of ODN and liposome, the
release of lactate dehydrogenase was measured using the LDH
KIT (Sigma). To determine the efficiency of MC transfection by
the ODN, we used FITC-labeled ODN and measured the per-
centage of MC nuclei that stained positive.
Based on these preliminary studies (see Results section), we
used the following experimental design in the current study. MC
were plated in 15% FCS at a density of 3 X iO cells/cm2 and
allowed to adhere overnight. MC were then washed three times
with serum free media, and the MC were left in serum free media
for 18 hours, At this time, the media was replaced with serum free
media containing either antisense ODN (1 nmol of antisense
ODN complexed with 1 j.tg/ml liposome), mismatch (1 nmol of
mismatch ODN complexed with 1 jig/mI liposome), or media
alone for six hours. MC were then washed three times with serum
free media, and the media was changed to serum free media
containing either PDGF (10 ng/ml), bFGF (10 ng/ml), PDGF (10
ng/ml) and TGF-/31 (1 ng/ml), bFGF (10 ng/ml) and TGF-/31 (1
— —
—
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Fig. 5. Effect of cyclin A expression measured by Western blot analysis in mesangial cells stimulated with PDGF. Mesangial cells (MC) were serum-starved
to achieve quiescence, then stimulated with either PDGF alone (10 ng/ml), or PDGF with TGF-pl (1 ng/mI). Twenty micrograms of MC protein was
loaded in each lane. yclin A protein was not detected in quiescent MC (lane 1). There was a progressive increase in cyclin A protein following
stimulation with PDGF, at 12 hours (lane 3) and 18 hours (lane 4), which was maximal at 24 hours (lane 5), when MC proliferation is at a peak. In
contrast, TGF-131, which reduces PDGF induced MC proliferation, prevents the increase in cyclin A expression induced by PDGF at 12 hours (lane 5),
and reduces the increase in cyclin A levels at 24 hours (lane 7). Protein molecular weight markers (in kDa) are shown in the left margin.
bFGF +
bFGF TGF-f31
Ohr l2hr l8hr 24hr l8hr 24hr
nglml), or serum free media alone. Proliferation was assessed at
12, 16, 20 and 24 hours after cytokine stimulation by 3H-
Thymidine and BrdU incorporation as described earlier. Each
experiment was performed a minimum of six times.
Statistics
All values are expressed as mean SEM, unless otherwise
stated. Statistical significance (P < 0.05) was evaluated using the
Student's t-test or one way analysis of variance with modified t-test
performed using the Bonferroni correction [28J.
Results
MC proliferation studies in non-transfected MC
The effects of PDGF, bFGF and TGF-/31 stimulation on rat
MC proliferation was assessed by measuring 3H-thymidine and
BrdU incorporation into DNA. Figures 1 and 2 show the results of
3H-thymidine incorporation, and similar to studies by others [5,
Fig. 6. Effect of bFGF on cyclin A expression by
Western blot analysis. Mesangial cells (MC)
were serum-starved to achieve quiescence, then
stimulated with either bFGF alone (10 ng/ml),
or bFGF with TGF-j31 (I ng/ml). Twenty
micrograms of MC protein were loaded in each
lane. Cyclin A protein was undetected in
quiescent MC (lane 1). There was a progressive
increase in cyclin A protein following
stimulation with bFGF, which was detected at
12 hours (lane 2), and maxiaml at 18 hours
(lane 3) and 24 hours (lane 4), when MC
proliferation is at a peak. In contrast, TGF-131,
which reduces bFGF induced MC proliferation,
prevents the increase in cyclin A expression
induced by bFGF at 18 hours (lane 5) and 24
hours (lane 6). Protein molecular weight
markers (in kDa) are shown in the left margin.
7], PDGF (P < 0.05 vs. control) and bFGF (P < 0.05 vs. control)
induce maximal DNA synthesis by 24 hours in non-transfected rat
MC. The addition of TGF-pl to PDGF or bFGF stimulated MC
reduced MC proliferation (P < 0.05 vs. PDGF alone; P < 0.05 vs.
bFGF alone), an observation that has been made previously [4—6,
121.
BrdU staining was used to determine the number of MC in S
phase of the cell-cycle following stimulation by PDGF and bFGF
with and without TGF-pl, and the results are shown in Figures 3
and 4. In serum-starved non-transfected MC, less than 10% of
MC stained positive for BrdU. Following stimulation with PDGF
40 1.5% of non-transfected MC stained positive for BrdU (P <
0.05 vs. control) and 42 1.9% stained positive for BrdU
following bFGF stimulation (P < 0.05 vs. control). Similar to the
results of the 3H-thymidine incorporation assay shown earlier, the
addition of TGF-J3 I to PDGF or bFGF stimulated MC reduced,
but did not completely prevent entry into the S phase (P < 0.05 vs.
PDGF alone; P < 0.05 vs. bFGF alone).
Ohr 6hr l2hr l8hr 24hr l2hr l8hr 24hr
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Fig. 7. Western blot analysis for cyclin dependent kinase 2 (CDK2). Mes-
angial cells (MC) were serum-starved to achieve quiescence, and then
stimulated with PDGF (10 ng/ml). A Western blot analysis was performed
on MC protein (20 tg in each lane) with an antibody to CDK2. Quiescent
MC (lane 1) express low levels of CDK2. Following stimulation with
PDGF, there is an increase in CDK2 at 12 hours (lane 2), 18 hours (lane
3) and 24 hours (lane 4). Protein molecular weight markers (in kDa) are
shown in the left margin.
Cyclin A expression increases during mesangial cell proliferation
We determined the protein expression of cyclin A by Western
blot analysis and immunostaining. Figure 5 shows a Western blot
analysis for cyclin A protein in MC stimulated by PDGF. Cyclin A
protein was undetectable in serum-starved MC, but there was a
progressive and substantial increase in cyclin A expression during
PDGF induced proliferation, first detected at 12 hours, and was
maximal at 24 hours. No cyclin A staining was detected in
quiescent MC. In contrast, the onset of MC proliferation was
associated with an increase in the number of cells with positive
intranuclear staining for cyclin A, first observed at 12 hours
following stimulation, and was maximal at 24 hours. Following 24
hours of PDGF stimulation 30% of MC expressed cyclin A (P <
0.05 vs. serum-starved MC). A similar increase in cyclin A levels
during MC proliferation following bFGF stimulation was seen by
Western blot analysis (Fig. 6). Coommasie staining showed that
the amount of protein loaded in each lane in all filters were equal.
CDK2 expression increases during mesangial cell proliferation
We determined the levels of CDK2 protein by Western blot
analysis and immunostaining. There was a low level of protein
expression for CDK2 in quiescent MC, where less than 10% of
cells were stained with the CDK2 antibody (results not shown).
PDGF and bFGF induced proliferation was associated with a
progressive and marked increase in the number of MC staining for
CDK2. At 12 hours 20% of cells were stained with the CDK2
antibody, while at 24 hours 30% of cells exhibited positive staining
for CDK2 (P < 0.05 vs. serum-starved MC). The increase in
staining did not represent an increase in total MC number, as the
number of MC did not increase during the time points chosen in
the current study. Figure 7 shows a Western blot analysis for
CDK2, and shows that similar to immunostaining, serum-starved
MC express low levels of CDK2. In contrast, MC proliferation was
associated with a substantial increase in CDK2 protein when
stimulated with PDGF (Fig. 7) and bFGF. Figure 8 shows the
results of inimunoprecipitation studies when mesangial cell pro-
tein was immunoprecipitated with an antibody to cyclin A, and a
Western blot analysis was performed with an antibody to CDK2.
Cyclin A associated with CDK2 during PDGF stimulation at 18
hours, when MC proliferation was significantly increased.
p27 expression is reduced during PDGF and bFGF induced
mesangial cell proliferation
Quiescent MC express high levels of p27 protein. Immunostain-
ing revealed that all quiescent MC expressed p27 as shown by the
dense intranuclear staining. Figure 9A shows a Western blot
analysis for p27 protein. Quiescent MC express p27 and the
protein levels did not change at 12 hours of PDGF stimulation,
when MC proliferation has not increased. In contrast, there was a
decrease in the levels of p27 at 18 hours and 24 hours following
PDGF stimulation, which was coincident with the onset of PDGF
induced MC proliferation. However, p27 expression was always
detectable. Figure IOA shows that the onset of MC proliferation
induced by bFGF was also associated with a reduction in levels for
p27, but in contrast to the levels during PDGF stimulation, the
decrease in p27 levels occurred earlier, and was more pronounced
than that observed for PDGF.
We performed immunoprecipitation studies to determine if p27
associated with cyclin A-CDK2 in quiescent and proliferating MC.
Figure 11 shows that the CKI p27 is bound to cyclin A-CDK2 in
quiescent MC. However, PDGF stimulation causes the dissocia-
tion of p27 from this complex, so that no p27 was complexed to
cyclin A-CDK2 during MC proliferation at 12 and hours.
TGF- 1 decreases cyclin A expression, and prevents the decrease
in p27 levels
As has been shown by others [13, 14], TGF-/31 in the current
study reduced but did not completely prevent PDGF and bFGF
induced MC proliferation (Figs. 1, 2, 3 and 4). Figures 5 and 6
show that TGF-131 prevents the maximal increase in cyclin A
expression at 24 hours that is induced by PDGF and bFGF
respectively. In contrast, TGF-/31 did not affect the levels of
CDK2 in PDGF or bFGF stimulated MC (results not shown).
The levels of p27 during TGF-/31 mediated reduction of PDGF
and bFGF induced MC proliferation was determined by Western
blot analysis, and are shown in Figures 9 and 10, respectively. In
MC stimulated with PDGF, TGF-f31 prevented the decline in p27
levels at 18 hours and 24 hours (Fig. 9B) that was observed when
MC were stimulated with PDGF alone. In MC stimulated with
bFGF, TGF-/31 not only prevented the decline in p27 levels at 18
hours and 24 hours, but appeared to actually increase the levels at
24 hours (Fig. lOB).
Because the association of p27 with cyclin A-CDK2 was de-
creased by PDGF and bFGF, we performed co-immunoprecipa-
tion studies to determine if TGF-131 prevented this dissociation.
Figure 11 shows that in the during the reduction of mesangial cell
proliferation by TGF-f31, p27 was complexed with cyclin A-CDK2.
Decreasing the levels of p27 is associated with an increased
proliferative response to PDGF and bFGF
We used antisense oligodeoxynucleotides (ODN) to reduce the
expression of p27 in rat MC, while mismatch ODN and untrans-
fected MC were used as controls. Using FITC-labeled ODN, we
determined that greater than 80% of MC were transfected
Ohr l2hr l8hr 24hr
n
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(results not shown). MC cytotoxicity associated with transfection
was examined by measuring LDH release at 6 and 24 hours.
Transfecting MC with ODN at concentrations greater than 5 nmol
caused cell lysis, but this did not occur at a concentration of I
nmol (results not shown). Cytotoxicity also occurred when MC
were transfected with liposomes alone at concentrations greater
than 2 ig/ml, but not when transfected with liposome at a
concentration of 1 tg/ml.
Based on these results, we selected a concentration of antisense
ODN and mismatch ODN of 1 nmol, which was complexed with
liposome at a final concentration of 1 j.tg/ml, and MC were
transfected for six hours. Figure 12 shows the levels of p27 protein
expression determined by Western blot analysis in MC that were
serum-starved and in MC stimulated by mitogens. In MC trans-
fected with mismatch ODN the levels of p27 were identical to
non-transfected MC. In contrast, p27 protein expression was
markedly reduced in MCs transfected with antisense ODN. The
levels of p27 in transfected MC were also determined by Western
blot analysis following PDGF and bFGF stimulation. The levels of
p27 were reduced in proliferating MC induced by PDGF that had
been transfected with mismatch. In contrast, there was a greater
reduction in p27 levels in proliferating MC that had been trans-
fected with antisense. Figure 12 also shows that p27 levels were
reduced by antisense when TGF-/31 was added to PDGF stimu-
lated cells. To ensure that the levels of other cell-cycle proteins
that we had shown to be important in MC proliferation were not
altered by transfection, we measured the expression of cyclin A
and CDK2. As shown in Figure 13, the levels of cyclin A and
CDK2 were not altered by transfecting MC with antisense or
mismatch. Furthermore, the levels of cyclin A and CDK2 were not
altered in transfected MC exposed to TGF-131 (results not shown).
The effects of p27 levels on MC proliferation induced by PDGF
are shown in Figures 1 and 3. Figure 1 shows that reducing the
levels of p27 with antisense ODN resulted in an increased
magnitude of MC proliferation as measured by 3H-thymidine
incorporation following stimulation with PDGF at 20 hours
compared to MC transfected with mismatch ODN (2236 125.5
vs. 1064 46.5 cpm4g protein, P < 0.05) and non-transfected
MC (2236 125.5 vs. 1166 100 cpm/ag protein, P < 0.05). At
24 hours of PDGF stimulation, MC proliferation remained in-
creased in the antisense trarisfected MC compared to mismatch
transfected MC (2297 300 vs. 1673 26.5 cpmlj.tg protein, P <
0.05) and non-transfected MC (2236 125.5 vs. 1816 81.8
cpm/ig protein, P < 0.05). Of interest, in MC transfected with
antisense ODN, there was no significant difference in prolifera-
tion following PDGF stimulation at 20 hours compared to 24
hours (2297 300 vs. 2236 125.5 cpm/.tg protein), whereas in
untransfected MC, proliferation was increased at 24 hours com-
pared to 20 hours (1816 81.8 vs. 1166 100 cpm/j.tg protein,
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Fig. 8. Immunoprecipitation of cyclin A. The
protein from serum-starved and PDGF
stimulated mesangial cells was
immunoprecipitated with an antibody to cyclin
A, seperated on a 15% SDS-PAGE, and a
Western blot analysis was performed with an
antibody to CDK2. Cyclin A complexes with
CDK2 at 18 hours of PDGF stimulation (lane
3), which coincides with a significant increase in
mesangial cell proliferation. Cyclin A did not
complex with CDK2 in serum-starved mesangial
cell (lane 1) or following 12 hours of PDGF
stimulation (lane 2).
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Fig. 9. A. Western blot analysis for 27Kq,1 following PDGF stimulation.
Serum-starved mesangial cells (MC) were stimulated with PDGF (10
nglml). For Western blot analysis, 20 jrg of MC protein was loaded in each
lane. Quiescent MC (lane 1) have high levels of p27'°' (p27) expression,
represented by a protein with a molecular weight of 27 kDa. These levels
are maintained at 12 hours (lane 2) following PDGF stimulation. There is
a decrease in p27 protein levels at 18 hours (lane 3) and 24 hours (lane 4)
following PDGF stimulation, and the decrease coincides with the onset of
MC proliferation. Protein molecular weight markers (in kDa) is shown in
the left margin. B. Western blot analysis for p271° during reduction of
PDGF induced proliferation by TGF-!31. Serum-starved rat MC were
stimulated with PDGF (10 ng/ml) and TGF-fIl (1 nglml). In contrast to
the decrease p27'<1 (p27) levels in MC stimulated to proliferate with
PDGF alone, the levels for p27 do not decrease when TGF-/31 is added to
reduce proliferation. Protein molecular weight markers (in kDa) is shown
in the left margin.
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Fig. 10. A. Western blot analysis fbr p27'°" following bFGF stimulation.
Quiescent mesangial cells (MC) were stimulated with bFGF (10 ng/ml).
For a Western blot analysis, 20 g of MC protein was loaded in each lane.
Quiescent MC (lane 1) have high levels of p271° (p27) expression,
represented by a protein with a molecular weight of 27 kDa. There is a
decrease in p27 protein levels at 12 hours (lane 2), 18 hours (lane 3) and
24 hours (lane 4) following bFGF stimulation, and the decrease coincides
with the Onset of MC proliferation. Protein molecular weight markers (in
kDa) is shown in the left margin. B. Western blot analysis for p27'<1
during reduction of bFGF induced proliferation by TGF-131. Quiescent rat
MC were stimulated with bFGF (10 nglml) and TGF-pl (1 ng/ml). In
contrast to the decrease p27KPl (p27) levels in MC stimulated to
proliferate with bFGF alone, the levels for p27 do not decrease when
TGF-pl is added to reduce proliferation. Protein molecular weight
markers (in kDa) is shown in the left margin.
P < 0.05). This indicates that the onset of maximal MC prolifer-
ation following PDGF stimulation occurred earlier when the p27
levels were lowered with antisense ODN. Similar results were
obtained using BrdU staining. As shown in Figure 3, in MC
stimulated with PDGF, there was a significant increase in BrdU
staining in MC transfected with antisense compared to both
non-transfected MC (56 1.0% vs. 40 1.5%, P < 0.05) and MC
transfected with mismatch (56 1.0% vs. 41 1.9%,P <0.05).
Although there was a trend towards increased MC proliferation at
12 and 16 hours of PDGF stimulation, there was no significant
difference in proliferation between the antisense transfected MC
compared to control (results not shown).
The effects of p27 levels on MC proliferation induced by bFGF
are shown in Figures 2 and 4, respectively. The magnitude of the
MC proliferative response measured by 3H-thymidine incorpora-
tion into DNA (Fig. 2) was greater at 20 hours in MC transfected
with antisense compared to non-transfected MC (2747 275 vs.
1462 95 cpm/j.tg protein, P < 0.0001) and mismatch transfected
MC (2747 275 vs. 1522 95 cpm/g protein, P < 0.0001). In
contrast to PDGF, there was no significant difference in MC
proliferation after 24 hours of bFGF stimulation in MC trans-
fected with antisense ODN compared with controls. Similar to the
results seen with PDGF, reducing the levels of p27 was not
associated with increased proliferation at 12 hours or 16 hours of
bFGF stimulation (results not shown). However, the onset of
maximal MC proliferation following bFGF stimulation was earlier
when the levels of p27 were reduced by antisense compared to
controls. Figure 4 shows the results of BrdU staining in MC
stimulated with bFGF. When MC were stimulated with bFGF
there was a marked increase in BrdU staining in MC with
following transfection with antisense ODN compared to non-
transfected MC (74 2.4% vs. 42 1.9%, P < 0.05) or MC
transfected with mismatch (74 2.4% vs. 40 2.8%, P < 0.05).
The proliferative effects of reducing p27 levels in MC depended
on the presence of mitogens. Our results show that there was no
difference in 3H-thymidine incorporation (Fig. 1) or BrdU stain-
ing (Fig. 3) between the MC transfected with antisense compared
to mismatch ODN and untransfected MC controls when serum-
free media was used. However, if MC were transfected with ODN
while plated in 15% FCS (as opposed to serum-free media), there
was an increased proliferation in MC transfected with antisense
ODN compared to control MC transfected with MSM OSN or
untransfected MC (P < 0.05).
We also studied the role of p27 on the effects of TGF-/31 on
PDGF and bFGF stimulated MC proliferation using 3H-thymi-
dine and BrdU incorporation, and the results are shown in Figures
1 to 4. In MC transfected with antisense or mismatch and in
non-transfected MC, the addition of TGF-pl reduced but did not
prevent MC proliferation induced by PDGF or bFGF (P < 0.05
PDGF alone, P < 0.05 vs. bFGF alone). Furthermore, there was
no significant difference in 3H-thymidine or BrdU incorporation
in transfected MC compared to non-transfected MC.
Discussion
We examined cell-cycle protein response in the glomerular MC
to various cytokines that have been shown to be important in
mediating MC proliferation in vitro. Although much is known
about cell-cycle proteins in non-renal cells, it is clear that the
expression of cell-cycle proteins during mitogenesis can vary in
individual cell types, and also may vary within a cell type depend-
ing on the mitogen. We therefore began our studies by determin-
ing the expression of various cell cycle proteins in the glomerular
MC in response to two mitogens, PDGF and bFGF. These
mitogens were chosen as there is substantial evidence that both
play a major role in the proliferative response of the MC both in
vitro and in t'ivo in the development of disease [2, 3].
Expression of cell-cycle proteins in response to mitogens
(PDGF and bFGF)
As previously shown, both PDGF [4, 5, 12] and bFGF [6]
induced substantial MC proliferation peaking at 24 hours. In the
current study we serially examined the expression cell-cycle
proteins during the 24 hours of mitogen stimulation to determine
the expression of G1-S cyclins. Cyclin A increased at 12 hours,
consistent with later GI, and similar to that observed in other cell
types [18]. However, the increase in CDK2 expression was a bit
unexpected when compared to non-renal cells, but consistent with
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Fig. 11. Co-immunoprecipitation of p27 and cyclin A-CDK2. Mesangial cell protein was immunoprecipitated with an antibody to cyclin A, separated on
a 15% SDS-PAGE, and a Western blot analysis was performed with an antibody to p27. In serum-starved mesangial cells (lane 1), p27 was complexed
with cyclin A-CDK2, and the association was lost in PDGF stimulated mesangial cells at 12 hours (lane 2) and 18 hours (lane 3). Molecular weight
markers (kDa) are shown in the left margin. p27 was complexed with cyclin A CDK2 in TGFJ3-1 stimulated mesangial cells.
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Fig. 12. Western blot analysis for p27'°"1 (p27) in mesangial cells transfected with specific oligodewcynucleotides (ODN). The level of p27 was determined
by Western blot analysis in non-transfected mesangial cells (MC) and MC transfected with mismatch oligodeoxynucleotides to p27 and with antisense
oligodeoxynucleotides to p27. The levels for p27 were high in serum-starved non-transfected MC (lane 1) and in MC transfected with mismatch (lane
2). In contrast, the levels for p27 were reduced in MC transfected with antisense p27 (lane 3). Stimulating MC to proliferate with PDGF (10 ng/ml)
resulted in a decrease in p27 levels in mismatch transfected MC (lane 4), but the levels were markedly decreased in MC transfected with antisense (lane
5). TGF-j31 did not increase the levels of p27 in mismatch transfected (lane 6) or antisense transfected (lane 7) mesangial cells.
our recent in vivo finding in the Thyl model of experimental
glomerulonephritis [291. The levels of p27 were reduced by PDGF
and bFGF. Similar results for PDGF has been shown by Coats
[271. Of interest was the finding that the more potent MC
mitogen, bFGF, was associated with a more substantial and earlier
reduction in p27 levels compared to PDGF. This observation
bFGF may account for increased MC proliferation compared to
PDGF stimulation. Furthermore, MC proliferation was associated
with a dissociation of this cyclin kinase inhibitor from the cyclin
A—CDK2 complex.
The levels of p27 in proliferating cells may be cell type specific,
and also may be determined by the mitogenic stimulus. For
suggested that the more pronounced reduction in p27 levels by example, MvlLu lung epithelial cells and human keratinocytes
GF-1
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retain a high level of p27 in their proliferative state, whereas the
levels of p27 in T cells, macrophages [30] and fibroblasts [31]
decline when stimulated to enter the cell cycle. However, in
contrast to the undetectable levels for p27 in fibroblasts, p27 levels
were always detected in proliferating MC. In human T cells, p27
maintains quiescence, and IL-2 induced proliferation in this cell
type is associated with a decrease in p27 expression, which is
prevented by rapamycin [31]. More recently Coats and colleagues
showed that IGF-l and EGF stimulation of Balb/c-3T3 cells was
not associated with a decrease p27 in expression [27]. One
possible explanation why there is only a partial decline in p27
levels with PDGF and bFGF induced MC proliferation in the
current study may reflect the fact that less than 40% of MC
proliferate in response to the mitogens used in this study, whereas
a higher number proliferate in other cell types. A second possi-
bility may be that different mitogens have a varied effect on p27.
The mechanism whereby p27 protein levels are reduced in MC are
unknown, but recent evidence suggests that there is increased
degradation of this protein during proliferation through the
ubiquitin pathway [32]. However, it is not known if PDGF or
bFGF directly increases p27 degradation.
Effect of TGF-f31 on reducing MC proliferation
TGF-/31 is an important cytokine thought to play a major role
in glomerular disease due to its ability to stimulate matrix [33, 34].
However, another important function of TGF-f31 is its ability to
reduce proliferation of MC that have been stimulated with
mitogens such as PDGF and bFGF [3, 12]. Similar to that shown
by Jaffer et a! [12], in the current study we show that rat MC
proliferation induced by PDGF and bFGF is reduced, but not
completely suppressed by TGF-f31. This effect was associated with
a reduction in cyclin A, but not CDK2 expression. The effect of
TGF-f31 on cyclin A has been shown in other cell types such as in
Mvl Lu cells [35], although more recent studies in this cell type
suggest that the decline in CDK2 activity by TGF-pl is more likely
due to a cyclin kinase inhibitor [24]. These authors showed that
TGF-/31 increased the CKI, p15, which displaced p27 from cyclin
D-CDK4 complexes, allowing p27 to inhibit cyclin E-CDK2
complexes. The effects of TGF-131 on different cyclins varies, and
TGF-f31 does not affect the levels of cyclin Dl or cyclin F [36, 37].
In the current study we showed that during inhibition of MC
proliferation, TGF-pl prevented the decrease in p27 levels in-
duced by PDGF and bFGF. Moreover, TGF-f31 increased p27
levels at 24 hours, when MC proliferation is maximal in the
absence of TGF-131. In addition to preventing a decrease in p27
levels in mesangial cells following mitogen stimulation, we showed
that TGF-f31 also prevented the dissociation of p27 from cyclin
A-CDK2 complexes during the reduction of proliferation. Be-
cause these results suggested to us that TGF-j31 may reduce
mesangial cell proliferation through p27, functional studies were
undertaken to address this hypothesis (see below).
Functional Studies of p27 in MC
The earlier experiments in the current study suggested that p27
may have a critical role in both PDGF and bFGF induced
proliferation (where p27 levels fall and dissociate from cyclin
A—CDK2), and for TGF-f31 reduction in proliferation (where
p27 levels maintained). However, while these results are impor-
tant in understanding the expression of specific cell-cycle proteins
in MC, these studies were descriptive. Therefore, we undertook
functional studies with antisense to p27 to determine the role of
this cyclin kinase inhibitor in MC proliferation. Antisense re-
agents have been successfully used to inhibit the synthesis of a
wide range of proteins [38, 39], including those involved in
cell-cycle progression such as CDC2 [40], myc [41] and myb [421.
Antisense inhibition of cyclin B synthesis was one of the first
demonstrations that cyclin synthesis was necessary for entry into
mitosis [43]. More recently, Coats et al used the same antisense,
mismatch and liposomes used in this study to show that p27 is
required for restriction point control in fibroblasts [27]. In the
a)0
a)
U)C
0Az
- a)o U)C
a)E
U) C
•0
a)0
a)
U) -C C)
E
B Z
a)
U)C
a)
U)
C
76— 76
*— Cyclin A
45• 45_
4— CDK2
29 29
Fig. 13. Western blot analysis for cyclin A and CDK2 in transfected mesangial cells (MC). The levels for cyclin A (A) and cyclin dependent kinase 2(CDK2) (B) are unchanged in proliferating MC stimulated by PDGF when transfected with mismatch oligonucleotides (lane 2) or with antisense
oligonucleotides (lane 3) compared to non-transfected MC (lane 1).
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current study we used mismatch oligodeoxynucleotides, which
have a similar sequence to the antisense, but the bases are
"scrambled." Because of potential cytotoxicity induced by trans-
fection, we ensured that the experimental conditions used did not
cause toxicity.
We show three major findings. First, in the absence of p27,
PDGF and bFGF proliferation in rat MC is of greater magnitude,
suggesting that p27 plays a critical role in the response to these
mitogens. Furthermore, the onset of maximal MC proliferation is
increased when the levels of p27 are reduced with antisense
compared to control. Second, lack of p27 by itself is not sufficient
to allow MC proliferation. Hence, serum starvation alone showed
no increased proliferation when p27 was eliminated. These results
suggest that proliferation requires both the loss of p27 and the
presence of a mitogen. Third, despite maintaining p27 levels,
TGF-/31 does not require p27 to reduce the proliferative effect of
PDGF and bFGF on rat MC. However, effects of TGF-f31 on
other cell-cycle proteins, such as p15 and p2l", should be
undertaken, as it has been shown by Morrissey et al that TGF-pl
increases p21Ct in the renal cortex in vivo [44].
In conclusion, we identified some of the cell-cycle regulatory
proteins that are activated in MC during proliferation. We have
shown a significant role for p27 in the proliferative response to
PDGF and bFGF. However, the maintainance of p27 by TGF-f31
is not critical by itself to block proliferation. These latter findings
are new to the cell-cycle in general. Further studies are needed to
determine the role of other cyclin kinase inhibitors in the prolif-
erative response.
Acknowledgments
Support for this study was provided by Public Health Service grants (DK
34198, DK43422, DK 51096, P50-47659). S.J.S. was also supported by a
grant-in-aid from the American Heart Association, Washington Affiliate
(97354).
Reprint requests to Stuart J. Shankland, M.D., Division of Nephrology,
University of Washington, P.O. Box 356521, Seattle, Washington 98195, USA.
E-mail: stuartjs@u. washington. edu
Appendix
Abbreviations are: MC, mesangial cell; PDGF, platelet-derived growth
factor; bFGF, basic fibroblast growth factor; TGF-pl, transforming
growth factor-/31; ODN, oligodeoxynucleotide; MSM, mismatch; p27,
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